Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $68.96 USD
Change Today +0.28 / 0.41%
Volume 669.1K
PRXL On Other Exchanges
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Josef H. von Rickenbach

Founder, Chairman and Chief Executive Officer, PAREXEL International Corporation
AgeTotal Calculated CompensationThis person is connected to 20 board members in 4 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Josef H. von Rickenbach has been the Chairman and Chief Executive Officer of PAREXEL International Corporation at California Clinical Trials Medical Group, Inc. since 1983. He founded PAREXEL International Corporation in 1982. Mr. von Rickenbach served as the President of PAREXEL International Corporation from July 2005 to July 1, 2012. He also served as the President of Parexel until April 2001. Prior to founding PAREXEL, Mr. von Rickenbach was employed by ENSECO ...

Read Full Background

Corporate Headquarters*

195 West Street
Waltham, Massachusetts 02451

United States

Phone: 781-487-9900
Fax: 781-487-0525

Board Members Memberships*

Founding Member and Director
Founder, Chairman and Chief Executive Officer


Harvard Business School
College of Economics and Administration, Lucerne

Other Affiliations*

Annual Compensation*

Total Annual Compensation$883,333

Stock Options*

Restricted Stock Awards$1,752,638
All Other Compensation$73,264
Exercised Options262,550
Exercised Options Value$7,297,232
Exercisable Options100,000
Exercisable Options Value$2,266,000
Unexercisable Options265,600
Unexercisable Options Value$5,657,384
Total Value of Options$15,220,615
Total Number of Options628,150

Total Compensation*

Total Annual Cash Compensation$1,994,122
Total Short Term Compensation$883,333
Other Long Term Compensation$1,825,902
Total Calculated Compensation$5,519,080
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRXL:US $68.96 USD +0.28


Colin Shannon Chairman, Chief Executive Officer and President
PRA Health Sciences, Inc.
James C. Foster J.D.Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Charles River Laboratories International, Inc.
Ari Bousbib Chairman, Chief Executive Officer and President
IMS Health Holdings, Inc.
Matthias Hartmann Chief Executive Officer and Member of Management Board
D. Jamie Macdonald Chief Executive Officer and Director
INC Research Holdings, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAREXEL INTERNATIONAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at